PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29763644-0	2018	Immunomodulatory effect of Celecoxib on HMGB1/TLR4 pathway in a recurrent seizures model in immature rats.	Celecoxib	27-36	toll-like receptor 4	Rattus norvegicus	46-50	
29763644-4	2018	In this study, the drug celecoxib (CCX) was used as a blocker of the cyclooxygenase 2 (COX-2) and HMGB1/TLR-4 pathways.	Celecoxib	24-33	toll-like receptor 4	Rattus norvegicus	104-109	
29763644-4	2018	In this study, the drug celecoxib (CCX) was used as a blocker of the cyclooxygenase 2 (COX-2) and HMGB1/TLR-4 pathways.	Celecoxib	35-38	toll-like receptor 4	Rattus norvegicus	104-109	
29763644-8	2018	When the CCX group was compared to the KA group, there was also a significant decrease in the number of HMGB1 and TLR-4 transcripts (p < 0.05) and in COX-2 protein expression (p < 0.05) in the most important areas for seizure generation (the hippocampus and cortex) at both the early and late time points.	Celecoxib	9-12	toll-like receptor 4	Rattus norvegicus	114-119